GaryBlickMD

Clinical Trials

• Safety and Effectiveness of Combining Hydroxyurea (HU) With Didanosine (ddI) and Stavudine (d4T) for Treatment of HIV-Infected Adults Start of enrollment: 1999 May 01

  Completed

  Phase 1

• A Comparison of Emtricitabine and Stavudine Used With Didanosine Plus Efavirenz in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs Start of enrollment: 2000 Aug 01

  Unknown status

  Phase 3

• A Rollover Study for Subjects Who Completed Participation in the VRX496-USA-05-002 Trial Start of enrollment: 2007 Dec 01

  Active, not recruiting

  Phase 2

• Safety and Efficacy Study of Switching From Epzicom to Truvada Start of enrollment: 2008 Jul 01

  Completed

  Phase 4

• Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Subjects Start of enrollment: 2010 Nov 01

  Completed

  Phase 1, Phase 2

• Dose Escalation Study of Cyclophosphamide in HIV-Infected Subjects on HAART Receiving SB-728-T Start of enrollment: 2011 Dec 01

  Completed

  Phase 1, Phase 2

• Study Assessing Dolutegravir in HIV-1 Infected Subjects With Virus Resistant to Raltegravir and/or Elivitegravir Start of enrollment: 2012 Apr 18

  Completed

  Phase 3

• Long-term Observational Study in HIV Subjects Exposed to EGRIFTA® Start of enrollment: 2013 Feb 01

  Terminated

• Repeat Doses of SB-728mR-T After Cyclophosphamide Conditioning in HIV-Infected Subjects on HAART Start of enrollment: 2014 Aug 01

  Completed

  Phase 1, Phase 2

• Safety and Efficacy of Doravirine (MK-1439) in Participants With Human Immunodeficiency Virus 1 (HIV-1) (MK-1439-018) Start of enrollment: 2014 Dec 01

  Completed

  Phase 3

• Safety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stem/Progenitor Cells in HIV-1 Infected Patients Start of enrollment: 2016 Mar 10

  Active, not recruiting

  Phase 1

• Join now to see all